DIABETIK DISLIPIDEMIYA VA YURAK-QON TOMIR KASALLIKLARI XAVFINING BAHOSI
Keywords:
Diabetik dislipidemiya, yurak-qon tomir kasalliklari, LDL xolesterin, HDL xolesterin, triglitseridlar, total xolesterin, ateroskleroz, kardiovaskulyar xavf, diabet.Abstract
Ushbu maqola diabetik dislipidemiya va yurak-qon tomir kasalliklari (YQTK) xavfi o‘rtasidagi bog‘liqlikni o‘rganishga bag‘ishlangan. Tadqiqotda diabetik bemorlarda lipid profili o‘zgarishlari, xususan LDL, HDL, triglitseridlar va total xolesterin darajalari, shuningdek, ular bilan bog‘liq kardiovaskulyar asoratlar riskini baholash tahlil qilinadi. Maqola natijalari glyukoza va lipid metabolizmini nazorat qilish orqali YQTK xavfini kamaytirish strategiyalarini aniqlash imkonini beradi.
References
1. American Diabetes Association. Standards of Medical Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl. 1):S1–S210.
2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581.
3. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20–33.
4. Colhoun HM, Betteridge DJ, Durrington PN, et al. Lipid and inflammatory markers in type 2 diabetes: relevance to cardiovascular risk. Diabetes. 2004;53(Suppl. 3):S109–S114.
5. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and lowdensity lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565.
6. Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38:1777–1803.
7. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357– 2368.
8. Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436–2443.
9. Fadini GP, Avogaro A. Biomarkers for cardiovascular risk in diabetes. J Diabetes Complications. 2015;29(6):918–923.
